Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Database | Last Updated |
---|---|
ChEBI | February 3, 2022 |
KEGG | February 3, 2022 |
LIPID MAPS Structure Database | February 3, 2022 |
LipidBank | February 3, 2022 |
PubChem | February 3, 2022 |
Main Class | Sub Class ▲ | LM ID | Common Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Glycerophosphoethanolamine glycans
|
1-(1Z-alkenyl),2-acylglycerophosphoethanolamine glycans
|
Am-PE(P-16:0/20:4(5Z,8Z,11Z,14Z))
|
885.573117
|
C47H84NO12P
|
|||||
Glycerophosphoethanolamine glycans
|
1-alkyl,2-acylglycerophosphoethanolamine glycans
|
Am-PE(O-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
911.588767
|
C49H86NO12P
|
|||||
Glycerophosphoethanolamine glycans
|
1-alkyl,2-acylglycerophosphoethanolamine glycans
|
Am-PE(O-20:0/20:4(5Z,8Z,11Z,14Z))
|
943.651367
|
C51H94NO12P
|
|||||
Glycerophosphoethanolamine glycans
|
1-alkyl,2-acylglycerophosphoethanolamine glycans
|
Am-PE(O-18:0/18:1(9Z))
|
893.635717
|
C47H92NO12P
|
|||||
Glycerophosphoethanolamine glycans
|
1-alkyl,2-acylglycerophosphoethanolamine glycans
|
Am-PE(O-18:0/18:2(9Z,12Z))
|
891.620067
|
C47H90NO12P
|
|||||
Glycerophosphoethanolamine glycans
|
1-alkyl,2-acylglycerophosphoethanolamine glycans
|
Am-PE(O-16:0/22:4(7Z,10Z,13Z,16Z))
|
915.620067
|
C49H90NO12P
|
|||||
Glycerophosphoethanolamine glycans
|
1-alkyl,2-acylglycerophosphoethanolamine glycans
|
Am-PE(O-18:0/20:4(5Z,8Z,11Z,14Z))
|
915.620067
|
C49H90NO12P
|
|||||
Glycerophosphoethanolamine glycans
|
1-alkyl,2-acylglycerophosphoethanolamine glycans
|
Am-PE(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
939.620067
|
C51H90NO12P
|
|||||
Glycerophosphoethanolamine glycans
|
1-alkyl,2-acylglycerophosphoethanolamine glycans
|
Am-PE(O-16:0/18:1(9Z))
|
865.604417
|
C45H88NO12P
|
|||||
Fatty acyl glycosides
|
Ascarosides
|
dhas#18
|
364.20972
|
C17H32O8
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01